| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |